K Number
K973285
Device Name
D/SENSE-T
Manufacturer
Date Cleared
1998-02-25

(176 days)

Product Code
Regulation Number
872.3200
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
To Reduce dentin sensitivity PRIOR TO cementing CROWNS, Bridges, etc. Also for Reducing dentin sensitivity in Class V CROSTOWSO
Device Description
Not Found
More Information

Not Found

Not Found

No
The summary contains no mention of AI, ML, image processing, or any other indicators of AI/ML technology. The intended use and device description (though not found) relate to a physical treatment for dentin sensitivity.

No
The device is used to reduce dentin sensitivity, which treats a condition rather than diagnosing or preventing it, but it does so prior to other procedures (e.g., cementing crowns), suggesting it's an adjunctive part of a dental procedure rather than a standalone therapeutic treatment in the traditional sense of curing a disease. It primarily addresses a symptom (sensitivity) to facilitate another procedure.

No
The device is described as reducing dentin sensitivity prior to cementing crowns, bridges, etc., and also for reducing sensitivity in Class V CROSTOWSO. This indicates a therapeutic or palliative function, not a diagnostic one.

Unknown

The provided 510(k) summary lacks a device description, making it impossible to determine if the device is software-only or includes hardware components.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is to reduce dentin sensitivity prior to cementing crowns, bridges, etc., and for reducing sensitivity in Class V restorations. This is a direct treatment applied to the patient's tooth structure (dentin).
  • IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body (like blood, urine, tissue) to detect diseases, conditions, or infections. They are used outside the body.

This device is applied in vivo (within the living body) to treat a condition directly on the patient. Therefore, it falls outside the scope of IVD devices.

N/A

Intended Use / Indications for Use

To Reduce dentin sensitivity PRIOR TO cementing CROWNS, Bridges, etc. Also for Reducing dentin sensitivity in Class V CROSTOWSO

Product codes

KLE

Device Description

Not Found

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

Not Found

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 872.3200 Resin tooth bonding agent.

(a)
Identification. A resin tooth bonding agent is a device material, such as methylmethacrylate, intended to be painted on the interior of a prepared cavity of a tooth to improve retention of a restoration, such as a filling.(b)
Classification. Class II.

0

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract image of an eagle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

EEB 2 5 1998

Mr. John Discko Executive Vice President Centrix Incorporated 770 River Road Shelton, Connecticut 06484-5458

K973285 Re : D/Sense-T Trade Name: Regulatory Class: II Product Code: KLE December 4, 1997 Dated: Received: December 9, 1997

Dear Mr. Discko:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major requlations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice for Medical Devices: General (GMP) regulation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of

1

Page 2 - Mr. Discko

the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as The FDA described in your 510(k) premarket notification. finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4692. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to
premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

Patricia Crescenti ffoe

Timothy A. Ulatowski Director Division of Dental, Infection Control, and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

K973885/111

Page of

510(k) NUMBER (IF KNOWN): K973285
DEVICE NAME: D/SENSE®-T
INDICATIONS FOR USE:
To Reduce dentin sensitivity
PRIOR TO cementing CROWNS,
Bridges, etc. Also for Reducing
dentin sensitivity in Class V
CROSTOWSO

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED. )

Sump
(Division Sign-Off)rence of CDRH, Office of Device Evaluation (ODE)
Division of Dental, Infection Control,
and General Hospital Devices
510(k) Number K973283
Prescription Use
(Per 21 CFR 801.109)
OR
Over-The-Counter-Use
(Optional Format 1-2-96)

Sk-31

100000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000